Moreover, HSF1 promotes tumour cell proliferation and metabolism by cytoprotective pathways [18–20] and it can also accelerate HCC development and act as a key determinant of HCC development by regulating hepatic steatosis and metabolic syndrome [21, 22]. This evidence concerns the gene HSF1 and fatty liver disease.